Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon

The idiopathic inflammatory myopathies (IIM) until recently have been considered a heterogeneous broad group of six autoimmune muscle diseases. Initially, autoantibodies in IIM (including JDM) and CD8+ T cell-...

Source: Pediatric Rheumatology - August 20, 2019 Category: Rheumatology Authors: Anjali Patwardhan and Charles H. Spencer Tags: Review Source Type: research